|
|
|
|
|
by _zbap
4012 days ago
|
|
Sorry, user logicallee explained this better than I did. You're looking at 4-5 graphs put next to each other for comparison. The nearest flatland with the huge towers is the one troubled clinic. Here's an annotated version of that, drawn by a child apparently: http://i.imgur.com/1dcuuXI.png As you can see, data of the clinic we were investigating is the first 6 long rows, and ones behind it are clinics we were not investigating. We asked to compare a number of clinics so not to tip our hand, and the administration took half a year of paranoid data checking before giving it to us. I know, not the most intuitive graph, but the graph was meant to be a diagnostic for only me, the person who composed the data. As you can see, a single glance at the graph revealed the problem, without involving any numerical analysis. |
|
His second paragraph was only about the one clinic in question, he ignored the other 3 in his second paragraph, though he wasn't explicit about this, and asked a year-over-year question about the drug, concerning clinic A only.
My point was kind of tangential, that, INCIDENTALLY if the colors matched up in the rows (were repeated in the same order 4 times) you could look at it another way visually that you can't right now without counting by hand. Specifically, you could look at the aggregate trend for all four clinics year-over-year for the drug in question (the one with the spike) by seeing with your eye how the six colors move as you move your eye from Stripe A, to Stripe B, to Stripe C, to Stripe D. Right now, with your eye you can only tell or ask about year-over-year changes for a specific drug for clinic A, not for the other ones. If all four 2009's were peach, you could easily tell if there were 4 spikes in that year or just one. In fact in 2009 all four do seem to spike somewhat. Not being able to visually see aggregate year-over-year comparisons is probably the downside to the current presentation.